95
Views
3
CrossRef citations to date
0
Altmetric
Review

Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection

&
Pages 531-542 | Published online: 19 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eric M. Maiese, Phaedra T. Johnson, Tim Bancroft, Alyssa Goolsby Hunter & Albert W. Wu. (2016) Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons. Current Medical Research and Opinion 32:12, pages 2039-2046.
Read now

Articles from other publishers (2)

K Vijaya Sri, M. Madhuri, V. Anusha & V.R.K. Siresha. (2019) DEVELOPMENT, VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF TENOFOVIR DISPROXIL FUMARATE, EMTRICITABINE AND RILPIVIRINE HYDROCHLORIDE IN BULK, FORMULATION AND USED IN NANOSUSPENSION. INDIAN DRUGS 56:09, pages 43-54.
Crossref
Sphamandla Ntshangase, Sipho Mdanda, Tricia Naicker, Hendrik G. Kruger, Thavendran Govender & Sooraj Baijnath. (2019) Rilpivirine as a potential candidate for the treatment of HIV-associated neurocognitive disorders (HAND). Journal of Molecular Histology 50:4, pages 295-303.
Crossref